From: A multidisciplinary opioid-reduction pathway for robotic prostatectomy: outcomes at year one
Matched data | Pre (n = 296) | Post (n = 152) | Total (n = 448) | p-value |
---|---|---|---|---|
Age | 61.6 (7.1) | 61.6 (7.0) | 61.6 (7.0) | 0.8755* |
Race |  |  |  | 0.5068†|
 Black | 64 | 39 | 103 |  |
 Other | 27 | 16 | 43 |  |
 White | 205 | 97 | 302 |  |
BMI | 29.5 (4.6) | 29.5 (4.7) | 29.5 (4.7) | 0.6424* |
BSA | 2.2 (0.21) | 2.2 (0.21) | 2.2 (0.21) | 0.4308* |
ASA score |  |  |  | 0.9144†|
 1 | 6 | 3 | 9 |  |
 2 | 131 | 68 | 199 |  |
 3 | 158 | 81 | 239 |  |
 4 | 1 | 0 | 1 |  |
Smoker | 35 | 24 | 59 | 0.2416‡ |
Chronic pain (current) | 17 | 10 | 27 | 0.8342‡ |
Chronic pain | 34 | 20 | 54 | 0.6466‡ |
Anxiety | 11 | 7 | 18 | 0.6217‡ |
Depression | 11 | 5 | 16 | 1‡ |
Mood disorder | 0 | 0 | 0 | N/A |
Drug use disorder | 1 | 1 | 2 | 1‡ |
Opioid tolerant | 1 | 1 | 2 | 1‡ |
Sleep apnoea | 29 | 15 | 44 | 1‡ |
Intraoperative opioid use (OME) | 39.7 (33.4) | 22.1 (44.3) | 33.73 (38.31) | .0001* |
Hospital LOS (days) | 1.5 (1.4) | 1.2 (0.8) | 1.4 (1.2) | .0047* |
Post-op antiemetics | Â | Â | Â | Â |
Any (Y/N) | 105 | 43 | 148 | 0.1259†|
Average no. of doses | 0.72 (1.4) | 0.44 (0.9) | 0.63 (1.3) | .0640* |
Post-op opioids (OME) | 47.0 (47.7) 34.5 [11.7, 67.5] | 32.7 (40.6) 17.5 [4.8, 47.1] | 42.2 (45.9) 29.7 [7.5, 63.1] | .0004* |
Recovery room stay (minutes) | 215 (199) | 167 (122) | 199 (178) | .0003* |
Average pain score | ||||
 In PACU | 3.5 [2, 5] | 3.8 [2, 5.2] |  | 0.512* |
 On ward | 2.9 [1.8, 4.1] | 2.7 [1.3, 3.8] |  | 0.208* |